United States - English - NLM (National Library of Medicine)

a-s medication solutions - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2)]. risk summary   the limited available data with desloratadine in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was not teratogenic at the summed area under the concentration-time curve (auc)-based exposures of desloratadine and its metabolite approximately 320 times that at the recommended human daily oral dose (r

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - desloratadine 5mg - film coated tablet - 5 mg - active: desloratadine 5mg excipient: colloidal silicon dioxide hydrogenated vegetable oil lactose microcrystalline cellulose opadry blue 03b50528 purified water starch

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - desloratadine -

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - desloratadine, quantity: 0.5 mg/ml - oral liquid, syrup - excipient ingredients: propylene glycol; sodium benzoate; sorbitol solution (70 per cent) (non-crystallising); sodium citrate dihydrate; disodium edetate; purified water; sunset yellow fcf; sucrose; citric acid; flavour - perennial and seasonal allergic rhinitis and chronic idiopathic urticaria in adults, adolescents and children aged 12 months and over. chronic idiopathic urticaria in adults, adolescents and children aged 6 months and over.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - desloratadine, quantity: 5 mg - tablet, film coated - excipient ingredients: mannitol; methylcellulose; zinc stearate; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin; indigo carmine aluminium lake - indicated for the relief of symptoms associated with seasonal and allergic rhinitis and chronic idiopathic urticaria.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - desloratadine, quantity: 5 mg - tablet, film coated - excipient ingredients: methylcellulose; zinc stearate; mannitol; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin; indigo carmine aluminium lake - indicated for the relief of symptoms associated with seasonal and allergic rhinitis and chronic idiopathic urticaria.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - desloratadine, quantity: 5 mg - tablet, film coated - excipient ingredients: mannitol; methylcellulose; zinc stearate; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin; indigo carmine aluminium lake - indicated for the relief of symptoms associated with seasonal and allergic rhinitis and chronic idiopathic urticaria.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - desloratadine, quantity: 5 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; silicon dioxide; microcrystalline cellulose; magnesium stearate; pregelatinised maize starch; titanium dioxide; sunset yellow fcf aluminium lake; purified talc; polyvinyl alcohol; macrogol 3350; indigo carmine aluminium lake - hayzep is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness and itching of palate.,hayzep is also indicated for the symptomatic relief of itching and reduction in the size and number of hives associated with chronic idiopathic urticaria.

Australia - English - Department of Health (Therapeutic Goods Administration)

adiramedica pty ltd - desloratadine, quantity: 0.5 mg/ml - oral liquid, syrup - excipient ingredients: sunset yellow fcf; glycerol; sodium benzoate; propylene glycol; sodium citrate; disodium edetate; citric acid monohydrate; sucrose; purified water; flavour - desloratadine syrup is indicated for relief from hayfever, year-round allergies and hives. relief of symptoms including sneezing, runny or itchy nose, itchy or watery eyes, itchy palate, itchy skin and hives

Australia - English - Department of Health (Therapeutic Goods Administration)

adiramedica pty ltd - desloratadine, quantity: 0.5 mg/ml - oral liquid, syrup - excipient ingredients: citric acid monohydrate; propylene glycol; purified water; sodium benzoate; sunset yellow fcf; sodium citrate; glycerol; disodium edetate; sucrose; flavour - desloratadine syrup is indicated for relief from hayfever, year-round allergies and hives.relief of symptoms including sneezing, runny or itchy nose, itchy or watery eyes, itchy palate, itchy skin and hives.